Low-dose Oral Thimerosal for the Treatment of Oral Herpes: Clinical Trial Results and Improved Outcome After Post-hoc Analysis

Background Thimerosal (TML) is an organomercury antimicrobial. Low doses (1/250 th of the amount in a typical vaccine dose) may promote an antiviral immune response. Low-dose TML (BTL-TML) was evaluated for safety and efficacy against herpes labialis in two FDA-approved, randomized, double blind, pl...

Full description

Saved in:
Bibliographic Details
Main Authors: Stephen W. Mamber (Author), Thomas Hatch (Author), Craig S. Miller (Author), John V. Murray (Author), Cynthia Strout (Author), John McMichael (Author)
Format: Book
Published: SAGE Publishing, 2022-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available